Tyrosinemia type- I, also known as hepatorenal tyrosinemia type 1 HT-1, is a genetic condition affecting the liver, kidneys, and central nervous system. The treatment involves a diet restricted in protein tyrosine and phenylalanine and daily administ
Related:
Senotherapeutic role
Senotherapeutic role of stem cells derived mitochondrial transfer in neurodegeneration: A study in in vitro and in vivo model of accelerated senescence
Research Project › Life Sciences & Biotechnology
This project aims to develop a multi-target ligand against Alzheimer's disease using donepezil and rivastigmine. The ligand will be designed using fragment-based drug design and in silico screening to identify potent anti-Alzheimer agents. The ligand
Related:
Point of
Point of care monitoring of neuro-vascular interaction ( especially inverse neurovascular coupling) during spreading depolarization's in brain trauma using simultaneous recording of EEG & NIRS
Research Project › Medical Sciences
Related:
Drug repurposing
Drug repurposing against key COVID-19 drug targets using advance machine learning-based algorithms
Research Project › Pharmaceutical Sciences
Antigenic variation
Antigenic variation in the malaria parasite Plasmodium falciparum: Measuring switching rates using single cell transcriptomics and machine learning
Research Project › Life Sciences & Biotechnology
Machine Learning-Guided
Machine Learning-Guided Discovery of Broad-Spectrum Antivirals Targeting Flaviviral Helicases
Research Project › Life Sciences & Biotechnology
Modern AI/ML-Integrated
Modern AI/ML-Integrated Physics-Based Protocols for Discovering Selective EphA2 and RTK inhibitors
Research Project › Chemical Sciences
Targeting oncogenic
Targeting oncogenic signaling of the atypical cadherin FAT1 by small molecules in a glioma tumor model
Research Project › Life Sciences & Biotechnology